Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...

A GP surgery in Attleborough has been urged to do more to ensure it learns from patient deaths following the inquest for an 81-year-old ...

New research highlights the significance of timing and tumour location when evaluating PSMA PET scans following radiotherapy ...

Doug Aldrich, a former guitarist with Whitesnake, Dio and currently The Dead Daisies, recently provided an update on his health after announcing last year that he was battling throat cancer. Per ...

A VISION-like, Single-Center Analysis Predicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer PSMA-Directed ...

Evan Yu, a medical oncologist, treats prostate, bladder ... Biomarkers, Imaging (PET scans, MRI), Bone health. Section Head, Cancer Medicine, Clinical Research Division Fred Hutchinson Cancer Center ...

The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

A clinical trial co-led by Yale Urology showed high resolution micro-ultrasound is an effective tool for guiding prostate ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 gozetotide in PSMA-PET scans.